ACCOUNTS - Final Accounts preparation

ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-31No description of principal activity2022-01-01false66truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12091658 2022-01-01 2022-12-31 12091658 2021-01-01 2021-12-31 12091658 2022-12-31 12091658 2021-12-31 12091658 c:CompanySecretary1 2022-01-01 2022-12-31 12091658 c:Director1 2022-01-01 2022-12-31 12091658 c:Director2 2022-01-01 2022-12-31 12091658 c:Director3 2022-01-01 2022-12-31 12091658 c:Director4 2022-01-01 2022-12-31 12091658 c:Director5 2022-01-01 2022-12-31 12091658 c:Director8 2022-01-01 2022-12-31 12091658 c:RegisteredOffice 2022-01-01 2022-12-31 12091658 d:CurrentFinancialInstruments 2022-12-31 12091658 d:CurrentFinancialInstruments 2021-12-31 12091658 d:Non-currentFinancialInstruments 2022-12-31 12091658 d:Non-currentFinancialInstruments 2021-12-31 12091658 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 12091658 d:CurrentFinancialInstruments d:WithinOneYear 2021-12-31 12091658 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 12091658 d:Non-currentFinancialInstruments d:AfterOneYear 2021-12-31 12091658 d:ShareCapital 2022-12-31 12091658 d:ShareCapital 2021-12-31 12091658 d:SharePremium 2022-12-31 12091658 d:SharePremium 2021-12-31 12091658 d:RetainedEarningsAccumulatedLosses 2022-12-31 12091658 d:RetainedEarningsAccumulatedLosses 2021-12-31 12091658 c:OrdinaryShareClass1 2022-01-01 2022-12-31 12091658 c:OrdinaryShareClass1 2022-12-31 12091658 c:OrdinaryShareClass1 2021-12-31 12091658 c:FRS102 2022-01-01 2022-12-31 12091658 c:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 12091658 c:FullAccounts 2022-01-01 2022-12-31 12091658 c:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 12091658 2 2022-01-01 2022-12-31 12091658 4 2022-01-01 2022-12-31 12091658 6 2022-01-01 2022-12-31 xbrli:shares iso4217:GBP xbrli:pure


Registered number: 12091658












NOVATIQ LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022


NOVATIQ LIMITED

CONTENTS



Page
Company information
 
1
Balance sheet
 
2 - 3
Notes to the financial statements
 
4 - 8



NOVATIQ LIMITED
 
COMPANY INFORMATION


Directors
J Hulford-Funnell 
S C Chandler  
J Curry 
T M Field 
G D Fink 
Y Akatsu 




Company secretary
T Wills



Registered number
12091658



Registered office
Marlborough House
Victoria Road South

Chelmsford

Essex

CM1 1LN




Accountants
Blick Rothenberg Limited
Chartered Accountants

16 Great Queen Street

Covent Garden

London

WC2B 5AH





- 1 -


        REGISTERED NUMBER:12091658
NOVATIQ LIMITED

BALANCE SHEET
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Fixed assets
  

Investments
 5 
2,700,001
2,700,001

Current assets
  

Debtors: amounts falling due within one year
 6 
9,946
43,418

Cash at bank and in hand
  
760,986
3,114,035

  
770,932
3,157,453

Creditors: amounts falling due within one year
 7 
(56,627)
(120,610)

Net current assets
  
 
 
714,305
 
 
3,036,843

Total assets less current liabilities
  
3,414,306
5,736,844

Creditors: amounts falling due after more than one year
 8 
(42,757)
-

Net assets
  
3,371,549
5,736,844


Capital and reserves
  

Called up share capital 
 9 
8,574,479
8,320,064

Share premium account
  
6,162,338
5,376,752

Profit and loss account
  
(11,365,268)
(7,959,972)

Total equity
  
3,371,549
5,736,844



- 2 -


        REGISTERED NUMBER:12091658
NOVATIQ LIMITED
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2022

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




G D Fink
Director

Date: 28 September 2023

The notes on pages 4 to 8 form part of these financial statements.


- 3 -



NOVATIQ LIMITED
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.


General information

Novatiq Ltd is a private company limited by shares incorporated in England and Wales. Its registered office address is Marlborough House, Victoria Road South, Chelmsford, Essex, United Kingdom, CM1 1LN.
The financial statements are presented in Sterling (£).

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

  
2.2

Exemption from preparing consolidated financial statements

The company, and the group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Going concern

After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least twelve months from the date these financial statements were approved. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the company but are presented separately due to their size or incidence.

 
2.7

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.


- 4 -



NOVATIQ LIMITED
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

  
2.9

Share capital

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

 
2.10

Financial instruments

The company has elected to apply Sections 11 and 12 of FRS 102 in respect of financial instruments.
Financial assets and financial liabilities are recognised when the company becomes party to the contractual provisions of the instrument. 
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. 
 

The company’s policies for its major classes of financial assets and financial liabilities are set out below. 
 
Financial assets
Basic financial assets, including trade and other debtors, cash and bank balances, intercompany working capital balances, and intercompany financing are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.
Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.
 
Financial liabilities
Basic financial liabilities, including trade and other creditors, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
 

- 5 -



NOVATIQ LIMITED
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

2.Accounting policies (continued)





Financial instruments (continued)

Impairment of financial assets
Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account. 
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset's carrying amount and the best estimate of the amount the company would receive for the asset if it were to be sold at the reporting date. 
For financial assets measured at amortised cost, the impairment loss is measured as the difference between the asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If the financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. 
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
 
Derecognition of financial assets and financial liabilities
Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions. 
 

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires. 
 
Offsetting of financial assets and financial liabilities
Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including directors, during the year was 6 (2021 - 6).


- 6 -



NOVATIQ LIMITED
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

4.


Exceptional items

2022
2021
£
£


Provision against debtor balances
3,231,170
3,287,767


5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2022
2,700,001



At 31 December 2022
2,700,001





6.


Debtors

2022
2021
£
£


Other debtors
1,323
39,369

Prepayments and accrued income
8,623
4,049

9,946
43,418



7.


Creditors: Amounts falling due within one year

2022
2021
£
£

Trade creditors
10,622
7,872

Other creditors
33,165
103,794

Accruals and deferred income
12,840
8,944

56,627
120,610



- 7 -



NOVATIQ LIMITED
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

8.


Creditors: Amounts falling due after more than one year

2022
2021
£
£

Other creditors
42,757
-


During the year, the convertible loans all converted into equity.


9.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



857,447,900 (2021 - 832,006,400) Ordinary shares of £0.01 each
8,574,479
8,320,064


During the year the company issued 978,518 Ordinary £0.01 shares at a premium of £0.0309 per share and 24,462,952 Series A £0.01 shares at a premium of £0.0409 per share. The shares issued were fully paid up.
An amount of £785,586 has been included in the share premium account in relation to these allotments.
As at 31 December 2022 the company had 147,257,720 employee share options granted over the Ordinary shares of the company. Options over Ordinary shares have been granted in various tranches from 2020 to 2022 at a strike price of £0.01 per share. There has been no charge recognised in the profit & loss account in respect of these options.


10.


Related party transactions

The company has taken advantage of the exemption contained in FRS 102 section 33 "Related Party Disclosures" from disclosing transactions with entities which are wholly owned part of the group.

 

- 8 -